T regulatory cells lacking CD25 are increased in MS during relapse. (Q53331257)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

title

T regulatory cells lacking CD25 are increased in MS during relapse (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

Angelica Loskog

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

Jan Fagius

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Moa Fransson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

Camilla Lindqvist

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

Christina Atterby

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

publication date

7 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

590-597

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

Multiple sclerosis and regulatory T cells

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

The role of CD4 CD25 T regulatory cells in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Crucial role of FOXP3 in the development and function of human CD25 CD4 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

The role of regulatory T cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3( ) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Phenotypic and functional analysis of CD4 CD25- Foxp3 T cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Decreased FOXP3 levels in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Natural naive CD4 CD25 CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

The T-cell pool is anergized in patients with multiple sclerosis in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

CD25 is a marker for CD4 thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25 and CD25- subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3 CD25 CD4 regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Foxp3 regulatory T cells in the control of experimental CNS autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Interferon-beta: mechanism of action and dosing issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4 CD25 regulatory T-cell function and FOXP3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08916930903541190

10.3109/08916930903541190

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20370571 AND SRC:MED&resulttype=core&format=json

30 January 2020

1 reference